HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
Activating Intelligence: Getting More from Your PLD Today—and Tomorrow
Activating Intelligence: Getting More from Your PLD Today—and Tomorrow
HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
Ideas, Insights, and Inspiration for Modern Healthcare Marketers
Explore our full library of resources developed by healthcare industry leaders aimed to spark actionable ideas.
Let's Talk
Want patients and providers talking about your brand? Talk to us first.
All Resources
18 results found
Patient-First Engagement: Navigating Privacy-Conscious Era
The healthcare industry thrives on innovation, and that includes the way it reaches patients. Traditionally, pharmaceutical marketers targeted patients via...
Digital Strategies to Streamline the Specialty Prescribing Workflow
Overcoming Disadvantaged Access Positions with Digital Tools at the Point-of-Care In almost every therapy area, utilization management, prior authorizations,...
The Impacts of Increasing Osteoarthritis Therapy Affordability
There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall...
Addressing Medication Affordability in Vulnerable Patients During COVID-19
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're...
Benchmark Your Market Access Digital Maturity
When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your...
Improving Access to Mental Healthcare with OptimizeRx Financial Messaging
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this...
Making the Case for a Digital Revolution in Market Access
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution....
The RWD Win/Win: A Strategy that Delivers for Pharma, Patients, HCPs and More
Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re...
A Data-Driven Approach that Improves Patient Care Journeys
Offering a Practical Approach to AI and Real World Data Despite incredible advances in the availability of real-world data (RWD) and AI applications, many...
HCP Targeting: Be there when your ideal patient and provider meet
Unlocking the Full Potential with Artificial Intelligence in Pharma Marketing At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to...
Key Themes from Overcoming Challenges in Multiple Sclerosis Treatment
Key Themes and Takeways from Our Multiple Sclerosis Series In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored...
Overcoming Patient Adherence Challenges in Multiple Sclerosis Treatment
Part Three of Our Multiple Sclerosis Series In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to...
Overcoming Initiation Challenges in Multiple Sclerosis Treatment
Part Two of Our Multiple Sclerosis Series In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier,...
Omnichannel Strategy Insights from Digital Pharma East 2021
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies...
Rare and orphan access trends in 2021
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that...
Advancing Oncology Treatment and Health Equity – An ASCO Recap
The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights...
OptimizeRx Specialty Solutions: Technology that Optimizes Your Access Support Ecosystem
As a scientist, I know first-hand how much time and energy go into the drug discovery and development process from day one. In fact, one of the highlights of...
What is your brand's plan after patent expiration and pharma LOE?
Medication switching by pharmacies can be one of the biggest challenges faced by loss of exclusivity (LOE) brands following patient expiration and the entrance...